annb0t
Top 20
With the business potentially at an important milestone, we thought we'd take a closer look at PolyNovo Limited's (ASX
NV) future prospects. PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. On 30 June 2023, the AU$911m market-cap company posted a loss of AU$4.9m for its most recent financial year. As path to profitability is the topic on PolyNovo's investors mind, we've decided to gauge market se...
>>> Read more: PolyNovo Limited (ASX
NV) Is About To Turn The Corner
>>> Read more: PolyNovo Limited (ASX